On November 1, 2024, biochemist Andreas Maurer will take up his professorship for Experimental Neurooncological Radiopharmacy at the Institute of Radiopharmaceutical Cancer Research at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR). This is a …
More